Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Carmen J CalfaMichael RothePam K MangatElizabeth Garrett-MayerEugene R AhnMonika L BurnessKeerthi GogineniNitin RohatgiTareq Al BaghdadiAlison ConlinAnu GabaOmid HamidJairam KrishnamurthyNaga Jyothi GaviniPhilip J GoldJordi Rodon AhnertJ Scott RobertsRamya ThotaGina N GranthamDominique C HinshawAbigail GregorySusan HalabiRichard L SchilskyPublished in: JCO precision oncology (2024)
alterations. Other treatments and clinical trials should be considered for these patient populations.